Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership625,388 shares
Latest Disclosed Value $ 483,199,783
Deutsche Bank Ag\ ownership in REGN / Regeneron Pharmaceuticals, Inc.

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 625,388 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $483,199,783 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 763,926 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -18.14% during the quarter.

Deutsche Bank Ag\ has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 625,388 -138,538 -18.14 483,200 -18.05 0.1597
2026-02-11 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 763,926 67,245 9.65 589,652 50.53 0.1920
2025-11-13 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 696,681 -14,156 -1.99 391,723 4.97 0.1313
2025-08-12 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 710,837 167,745 30.89 373,189 8.35 0.1374
2025-05-09 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 543,092 3,823 0.71 344,445 -10.33 0.1365
2025-06-30 2024-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 539,269 96,329 21.75 384,137 -17.50 0.1504
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 539,269 96,329 384,137 0.1499
2025-06-26 2024-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 442,940 41,768 10.41 465,636 10.43 0.1895
2024-11-13 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 442,940 41,768 465,636 0.1895
2025-06-12 2024-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 401,172 89,096 28.55 421,644 40.37 0.1902
2024-08-14 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 401,172 89,096 421,644 0.1902
2025-06-02 2024-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 312,076 -13,319 -4.09 300,370 5.10 0.1394
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 312,076 -13,319 300,370 0.1394
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 325,395 53,764 19.79 285,791 27.85 0.1458
2023-11-24 2023-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 271,631 -28,150 -9.39 223,541 3.78 0.1444
2023-11-09 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 271,631 -28,150 223,541 0.0294
2023-08-14 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 299,781 -2,971 -0.98 215,405 -13.41 0.1145
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 302,752 -21,286 -6.57 248,762 6.40 0.1385
2023-02-13 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 324,038 -1,216 -0.37 233,790 4.34 0.1345
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 325,254 -37,570 -10.35 224,056 4.47 0.1352
2022-08-11 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 362,824 -49,181 -11.94 214,476 -25.47 0.1197
2022-05-13 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 412,005 -2,936 -0.71 287,754 9.81 0.1342
2022-02-16 2021-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 414,941 -34,017 -7.58 262,045 -3.55 0.1178
2022-02-11 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 414,941 -34,017 262,045 0.1175
2021-11-04 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 448,958 -52,753 -10.51 271,700 -3.04 0.1289
2021-08-11 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 501,711 37,449 8.07 280,225 27.57 0.1361
2021-05-13 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 464,262 34,491 8.03 219,660 5.80 0.1183
2021-02-16 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 429,771 52,914 14.04 207,626 -1.58 0.1268
2020-11-12 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 376,857 15,336 4.24 210,956 -6.43 0.1451
2020-08-13 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 361,521 -29,797 -7.61 225,461 17.99 0.1714
2020-05-14 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 391,318 -82,329 -17.38 191,077 7.44 0.1706
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 473,647 -155,540 -24.72 177,841 1.90 0.1159
2019-11-14 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 629,187 33,249 5.58 174,532 -6.43 0.1212
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 595,938 82,934 16.17 186,524 -11.45 0.1095
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 513,004 22,918 4.68 210,645 15.08 0.1254
2019-04-01 2018-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 490,086 6,798 1.41 183,041 -6.26 0.1298
2019-02-14 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 490,086 189,636 183,041
2021-12-21 2018-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 483,288 -308,666 -38.98 195,269 -28.53 0.0987
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 300,450 -491,504 121,391 0.0839
2020-04-21 2018-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 791,954 -357,012 -31.07 273,216 -30.95 0.1361
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 554,928 -594,038 191,440 127,153.9709
2019-10-23 2018-03-31 13F/A-2 REGENERON PHARMACEUTICALS COM 75886F107 1,148,966 611,885 113.93 395,653 95.95 0.1888
2019-10-18 2018-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 1,148,966 0 395,653 0.1888
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 761,473 224,392 262,217
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 537,081 272,122 102.70 201,918 70.45 0.1293
2017-11-14 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 264,959 46,994 21.56 118,465 10.67 0.0812
2017-08-11 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 217,965 -39,558 -15.36 107,048 7.27 0.0764
2017-05-15 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 257,523 45,536 21.48 99,790 28.24 0.0737
2017-02-14 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 211,987 -61,354 -22.45 77,815 -29.18 0.0626
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 273,341 -18,371 -6.30 109,884 7.86 0.0778
2016-08-15 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 291,712 20,223 7.45 101,872 4.11 0.0719
2016-05-16 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 271,489 2,015 0.75 97,853 -33.11 0.0737
2016-02-16 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 269,474 -104,699 -27.98 146,287 -15.95 0.1012
2015-11-17 2015-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 374,173 -122,531 -24.67 174,038 -31.31 0.1345
2015-08-12 2015-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 496,704 -141,560 -22.18 253,379 -12.07 0.1617
2015-05-15 2015-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 638,264 -48,411 -7.05 288,160 2.29 0.1792
2015-02-13 2014-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 686,675 -31,895 -4.44 281,704 8.74 0.1738
2014-11-14 2014-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 718,570 -21,508 -2.91 259,054 23.92 0.1608
2014-08-15 2014-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 740,078 -104,757 -12.40 209,045 -17.60 0.1420
2014-05-15 2014-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 844,835 -87,551 -9.39 253,684 -1.15 0.1802
2014-02-24 2013-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 932,386 -172,563 -15.62 256,625 -25.77 0.1845
2014-02-18 2013-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 932,386 256,625
2013-11-18 2013-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,104,949 691,649 167.35 345,701 271.97 0.2552
2013-08-16 2013-06-30 13F REGENERON PHARMACEUTICALS COM 075886F10 413,300 413,300 92,938 0.0762
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM Call 10 -93.87 4 -93.33 n/a n/a n/a
2019-04-01 2018-12-31 13F/A REGENERON PHARMACEUTICALS COM Call 163 0.00 60 -9.09 n/a n/a n/a
2019-02-14 2018-12-31 13F REGENERON PHARMACEUTICALS COM Call 163 60 n/a n/a n/a
2021-12-21 2018-09-30 13F/A REGENERON PHARMACEUTICALS COM Call 163 0.00 66 17.86 n/a n/a n/a
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM Call 163 65 n/a n/a n/a
2020-04-21 2018-06-30 13F/A REGENERON PHARMACEUTICALS COM Call 163 0.00 56 0.00 n/a n/a n/a
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COM Call 163 56 n/a n/a n/a
2019-10-18 2018-03-31 13F/A REGENERON PHARMACEUTICALS COM Call 163 56 n/a n/a n/a
2019-10-23 2018-03-31 13F/A REGENERON PHARMACEUTICALS COM Call 163 0.00 56 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM Call 163 56 n/a n/a n/a
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F REGENERON PHARMACEUTICALS COM Call 33 14 n/a n/a n/a
2015-05-15 2015-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-13 2014-12-31 13F REGENERON PHARMACEUTICALS COM Call 72 -79.43 29 -6.45 n/a n/a n/a
2014-02-24 2013-12-31 13F/A REGENERON PHARMACEUTICALS COM Call 350 0.00 31 -24.39 n/a n/a n/a
2014-02-18 2013-12-31 13F REGENERON PHARMACEUTICALS COM Call 350 31 n/a n/a n/a
2013-11-18 2013-09-30 13F REGENERON PHARMACEUTICALS COM Call 350 0.00 41 115.79 n/a n/a n/a
2013-08-16 2013-06-30 13F REGENERON PHARMACEUTICALS COM Call 350 19 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-10-23 2018-03-31 13F/A REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM Put 150 56 n/a n/a n/a
2017-05-15 2017-03-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F REGENERON PHARMACEUTICALS COM Put 80 0.00 29 -9.37 n/a n/a n/a
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM Put 80 32 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.